Safety

General Health Information about Influenza Vaccination

On this page:


What is influenza?

Influenza, commonly known as the flu, is an acutely infectious respiratory disease 1-6 affecting both humans and animals, caused by the family influenza viruses (Orthomyxoviridae).1 Influenza is usually mistaken for the common cold, however, it is considered to be a much more serious illness and a very different type of virus.1-6

Influenza is an airborne virus. It is expelled from infected individuals via droplets from sneezing, coughing, blowing their nose and even talking, and this is in turn inhaled by the next victim.1-8 An estimated 10-15% of the world's population will contract Influenza per year,9,10 with as many as 50% during a pandemic.

The most frequent symptoms in humans apart from general discomfort are fever and chills, cough, sore throat, runny nose, malaise (weakness), generalised muscular and joint pains and severe headaches.1-8 Influenza is regarded as a moderately severe illness in healthy adults but in individuals who are already unwell or with chronic ailments, influenza can be very severe or even fatal with secondary bacterial complications like pneumonia arising predominantly in the elderly or young children.2-7 Nausea and vomiting may be present, especially in children, though this may be unrelated.

The symptoms of influenza infection generally last 3-5 days (can last as long as 7 days); the cough and fatigue may persist for several days, wheezing may persist for 6-8 weeks.3

The period between infection and onset of symptoms is 1-4 days. A person may be contagious 1 day before symptoms appear and for 3-7 days after the onset of symptoms.

top of page

Why is it so contagious?

The University is a multicultural and multinational environment, with a very mobile population, where people are coming and going from exotic and not so exotic places every day. In addition, the staff, students and visitors are confined in very small areas. As mentioned above, Influenza is a highly infectious organism spread by droplets via coughing, sneezing or even talking.

top of page

How does it affect me?

Deaths accredited to influenza occur primarily from complications, including pneumonia, obstructive airways and cardiac disease. Occurring primarily in individuals with chronic conditions, infants less than 6 months and those aged above 65 years.3 Any given individual will be in contact with others who may be a high risk of developing complications from influenza. We all have friends with asthma, heart conditions and diabetes. We all know people over 65 or have friends with infants.

top of page

Why should I be immunised?

Anyone who is in the high risk category should me immunised. As the University has a highly mobile multinational teaching and research institution we automatically fall into a higher risk level due to the potential exposures. Please refer below for other risks:

Source: http://www.fightflu.gov.au/are_you_at_risk [decommissioned]

top of page

What is influenza vaccination?

The Influenza vaccination is an intramuscular or deep subcutaneous injection of 0.5 ml of Inactivated Split Influenza vaccine into the upper arm.

The Vaccines must conform to the seasonal/annual recommendations of the World Health Organization (WHO) and the Australian Influenza Vaccine Committee (AIVC) this requires the type and amount of viral antigens, within the vaccine, to conform to the season standards established by the above groups12.

Vaccination occurs in a room set aside in the workplace, with staff groups vaccinated in the one session. It usually takes only a few minutes to complete the procedure. Once vaccinated the individual is required to wait for approximately 10-15 minutes as a precaution, in case of allergies developing.

top of page

Is influenza vaccination effective?

In healthy, working adults influenza vaccination has been shown to:

when compared with healthy working adults who had received a placebo5.

Please Note: This influenza vaccine will not protect you or your child against Influenza-like-illnesses (ILI), which can be caused by other viruses and bacteria.

top of page

Is influenza vaccination safe?

The Influenza vaccine does not cause influenza, and does not contain live virus. Generally, people have no reaction to the vaccine although some may experience side effects such as tenderness and redness at the site. This usually clears within a day or two of vaccination.13

There are instances where people should not receive influenza vaccine, for example those who are allergic to eggs or the chicken products used to prepare the vaccine. Prior to each individual vaccination, people complete a checklist that covers the circumstances in which vaccination should not take place. At the time of vaccination staff then confirm information on the checklist and are available to answer any questions related to this information.

Vaccination is only administered by trained and authorised staff, experienced in managing all situations associated with vaccination.

top of page

Is influenza vaccination compulsory?

No. The decision to be vaccinated is completely voluntary.

top of page

What is the cost of the influenza vaccination?

On average absenteeism of 10-12% of the work force can be attributed to influenza in any given year,8,9 not taking pandemics into account which may bring this figure up to over 50%.

The advantages of vaccination in economic terms, estimating both the direct and indirect costs associated with developing upper respiratory illnesses and immunization, indicated a saving of $46.85 (US) per person vaccinated (estimates at 1995 figures)5, which has increased to $58.36 was saved per staff member vaccinated14. Unfortunately the limitation of the above figures is that it cannot take into account the social cost and the personal out of pocket cost of individuals and families affected with the illness.

Spending money to protect staff from contracting influenza is cost-effective. A study of healthy employees provided with influenza vaccination prior to a mild flu season realised significant savings cost by vaccinating staff14 (cost was determined by vaccine and administration cost, time spent being vaccinated and lost time associated with side effects of vaccination). The savings are more pronounced in years where there are more widespread or severe influenza strains present.

Costs are borne by the Department/Division - refer to Current Year's Program.

The cost for University staff and post graduate student is free if your Department/Faculty has agreed to the program.

Workload Issues

Staff not at work due to influenza increases pressure on those staff remaining at work. This may adversely impact staff wellbeing, reduce overall productivity and slow processing of essential tasks

Safety Issues

Influenza can slow reaction times by 20-40% for those who continue to work whilst ill, increasing the possibility of error or injury(15).

top of page

How long will the vaccination offer protection from influenza?

Protection is gained within 2 to 3 weeks; the amount of antibodies in the body is greatest 1 or 2 months after vaccination and then gradually declining over a 6 to 12 month period. It is therefore important to plan a vaccination program before there is an increased probability of infection from contact with others12.

The strains included in the Australian vaccine for the current year are listed under Current Year's Program.

top of page

Should I be vaccinated again this year?

In short, the answer is Yes. Protection diminishes with time and influenza strains can change, therefore it is recommended that vaccination be considered every twelve months.

2007 saw the most severe influenza season since national reporting of influenza began in 2001 in General Practice16. In the same period the influenza vaccination rate was the lowest in recent years16-18. This period also marked an increase in ILI attributed to the low vaccination rate for the year.

It was also noted the absenteeism for the same time frame increased to the highest point since records began17, 18.

top of page

Further Information

Further information can be obtained from the Occupational Health Nurse.

The following public health resources are also available:

 

top of page

References

  1. Mosby's Dictionary of Medicine, Nursing & Health Professions 7th Edition. Mosby Elsevier 2005.
  2. Eccles, R. "Understanding the symptoms of the common cold and influenza". The Lancet Infectious Diseases, Volume 5, Issue 11, Pages 718 - 725, Nov 2005. Viewed 7 Jan 2009 @ http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(05)70270-X/fulltext
  3. The Merck Manual-Online Medical Library-Home Edition, Influenza. Viewed 6 Jan 09 @ http://www.merck.com/mmhe/sec17/ch198/ch198d.html. Last Reviewed Feb 2007.
  4. Nichol KL. Clinical effectiveness and cost-effectiveness of influenza vaccination among health working adults. Vaccine 1999; 17:567-73.
  5. Nichol, KL et al. The effectiveness of vaccination against influenza in healthy working adults. New England Journal of Medicine 1995; 333(14); 889-893, 5 Oct 1995.
  6. Nichol K.L. Mallon K.P. Mendelman P.M. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine 21 (2003) 2207 2217
  7. Skull, S. Effectiveness of influenza and pneumococcal vaccination against hospitalisation for community-acquired pneumonia among persons >=65 years. PhD thesis, School of Population Health and Department of Medicine, The University of Melbourne. 2007. Viewed 12 Jan 2009.
  8. Blue book - Guidelines for the control of infectious diseases Influenza. Viewed 6 Jan 2009, Last reviewed 15 Jan 2008, http://www.health.vic.gov.au/ideas/bluebook/influenza.
  9. Grandi P. and Franco G. Practicing evidence-based occupational health in workers groups: how to prevent sickness absence caused by Influenza. Occupational Medicine 2005; 55: 79.
  10. O'Reilly FW, Stevens AB. Sickness absence due to Influenza. Occupational Medicine (London) 2002; Aug 52 (5) 265-9.
  11. Australian Government National Health and Medical Research Council. Health Professionals. Viewed 7 Jan 2009 @ http://www.fightflu.gov.au/professionals#economics [decommissioned] Last updated 8 December 2008.
  12. Sanofi Pasteur Product Information. VAXIGRIP VAXIGRIP Junior Inactivated Influenza Vaccine (Split Virion). Date amended 13 Oct 2008. Sanofi Pasteur.
  13. Australian Government Department of Health and Ageing: National health and Medical Research Council. The Australian Immunisation Handbook 9th Ed 2008. Jan 2008.
  14. Cohen P. Darling C. Hampson A. Downs K. and Tasset-Tisseau A. Influenza vaccination in an occupational setting: effectiveness and cost-benefit study. Journal of Occupational Health and Safety Australia and New Zealand 2003, 19 (2): 167-182.
  15. Smith A.P. Thomas M. Brockman P. Kent J. and Nicholson K.G. Effect of influenza B virus infection on human performance. British Medical Journal, 1993, 306; 760-61. http://www.bmj.com.ezp.lib.unimelb.edu.au/cgi/reprint/306/6880/760 Viewed 9 March 2009.
  16. Charles J. Harrison C. Britt H. Influenza. Australian Family Physician Vol. 37, No. 10, Oct 2008. Viewed 7 Jan 2009 @ http://www.racgp.org.au/afp/200810/200810charles.pdf.
  17. Owen R. Barr I.G. Pengilley A. Liu C. Paterson B. and Kaczmarek M. Annual Report of the National Influenza Surveillances Scheme, 2007. Australian Government Department of Health and Ageing: Communicable Diseases Intelligence 2008; Vol 32, No 2. Viewed 7 Jan 2009 @ http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-cdi3202b.htm. Last Review 30 June 2008.
  18. The Royal Australian College of General Practitioners. Australian Sentinel Practices Research Network ASPREN. Newsletter No. 4, Sept 2007. Viewed 7 Jan 2008 @ http://www.racgp.org.au/Content/NavigationMenu/Advocacy/ IssuesinGeneralPractice/Publichealth/aspen/200709ASPREN_newsletter.pdf Posted Sept 2007.
top of page